Science and Technology

Hard-to-abate sectors like cement, steel, chemicals, refining, and heavy transport generate a significant portion of worldwide industrial emissions. High-temperature heat, chemical reactions, or fossil-derived inputs underpin these industries, making direct electrification alone insufficient for their replacement. With net-zero goals becoming more stringent, carbon capture has stepped forward as a pivotal mechanism for handling greenhouse gases that evade elimination via efficiency gains or alternative fuels.Recent years have seen a shift from pilot-scale experimentation toward commercially oriented deployment. The trends below highlight how carbon capture is evolving to meet industrial, economic, and regulatory realities.From Single-Plant Projects to Industrial HubsOne of the primary…

Perovskite solar cells are a class of photovoltaic devices that use a perovskite-structured material as the light-absorbing layer. Over the past decade, they have moved from laboratory curiosities to serious contenders in the global solar market. Their appeal lies in a combination of high power conversion efficiency, low manufacturing cost, and design flexibility. Laboratory efficiencies have climbed rapidly, from below 4 percent in the early 2010s to over 26 percent in single-junction cells and above 33 percent in tandem configurations when combined with silicon.This rapid pace of advancement is totally unprecedented within the solar energy sector, sparking immense curiosity amongst…

Electrolyzers use electricity to separate water into hydrogen and oxygen, and their overall economics shape whether clean hydrogen can rival fossil-based options in sectors such as industry, transportation, and energy storage. In the past, limited efficiency and high upfront costs restricted widespread use. Over the last decade, materials science has driven major advances, transforming catalysts, membranes, electrodes, and structural elements. These innovations have steadily reduced system costs per kilowatt while boosting efficiency and operational lifespan.The main cost drivers in electrolyzersElectrolyzer cost is not dominated by a single part. Improvements therefore come from multiple material upgrades rather than one breakthrough.Catalysts: precious…

Messenger RNA platforms have moved far beyond their early identity as vaccine technologies. Their expansion into oncology, rare diseases, cardiovascular medicine, and beyond reflects a convergence of scientific validation, manufacturing advantages, regulatory learning, and unmet clinical need. The same properties that enabled rapid pandemic response are now being leveraged to reshape how medicines are designed and delivered.From Proof of Concept to Broad Clinical ConfidenceThe worldwide rollout of mRNA vaccines offered extensive real-world confirmation that synthetic mRNA can be effective, scalable, and generally well tolerated, with hundreds of millions of administered doses showing that short-lived protein production can trigger strong immune…

The Technological Evolution Reshaping Modern AgricultureAgriculture is undergoing a profound transformation driven by drones and robotic systems. These technologies are reshaping how farmers monitor crops, detect stress, and apply inputs such as fertilizers and pesticides. By combining aerial intelligence, ground-based robotics, and data analytics, modern farms are becoming more precise, efficient, and environmentally responsible.How Drones Enhance Crop Surveillance EffortsDrones, also known as unmanned aerial vehicles, have become essential tools for real-time crop observation. Equipped with advanced sensors and cameras, they provide insights that were previously expensive or impossible to obtain at scale.Multispectral and hyperspectral imaging: These instruments collect information far…

Artificial intelligence is swiftly shifting from small-scale trials to essential, high-stakes applications within regulated fields like finance, healthcare, energy, telecommunications, insurance, and pharmaceuticals, and as AI increasingly shapes decisions carrying legal, ethical, and social consequences, oversight has ceased to be optional and is instead evolving into a fundamental obligation driven by regulatory pressure, risk mitigation, and public responsibility.The Expanding Role of AI in High-Stakes EnvironmentsRegulated industries adopt AI to improve efficiency, accuracy, and scalability. Examples include credit scoring models in banking, diagnostic algorithms in healthcare, fraud detection in insurance, algorithmic trading in capital markets, and predictive maintenance in utilities. These…

Drug discovery has long been a slow, costly, and high‑stakes endeavor, often requiring more than ten years and enormous financial investment before a single therapy reaches the market. Breakthroughs in artificial intelligence and protein folding tools are now transforming this process by greatly enhancing how researchers interpret biological targets, craft potential drug molecules, and anticipate their effects. As these innovations advance, development timelines are shrinking, expenses are decreasing, and therapeutic possibilities once considered unattainable are becoming viable.The Central Role of Protein Structure in Drug DiscoveryMost drugs work by binding to proteins and altering their activity. To design effective molecules, researchers…

Personalized medicine aims to tailor prevention, diagnosis, and treatment to the unique biological traits, environmental conditions, and lifestyle patterns of each patient, and over the past decade this concept has gradually become part of standard practice, shaping how therapies are developed and how clinical trials are designed. Advances in genomics, data science, and digital health continue to propel this shift, while regulatory agencies and healthcare organizations adjust their approaches to support more precise, individualized, and patient-centered research models.Genomics and Multi-Omics as Foundational DriversThe sharp decline in genome sequencing costs and the rise of multi-omics technologies have fundamentally altered personalized medicine.Genomics:…

Digital biomarkers are objective, quantifiable physiological and behavioral data collected through digital devices such as smartphones, wearable sensors, and connected medical tools. Unlike traditional biomarkers, which often rely on laboratory tests or in-clinic measurements, digital biomarkers are generated continuously in real-world settings. They capture signals like heart rhythm, physical activity, sleep patterns, voice characteristics, typing behavior, and movement dynamics, transforming everyday interactions with technology into health insights.Shifting from Occasional Treatment to Ongoing MonitoringTraditional health monitoring is typically episodic, based on occasional clinic visits and short diagnostic tests. Digital biomarkers shift this model toward continuous observation. Wearable devices can track heart…

Zero-knowledge proofs, or ZKPs, first emerged within academic cryptography and later entered the public spotlight through blockchain technology and privacy-driven cryptocurrencies. Their fundamental appeal lies in a remarkable idea: a party can verify the truth of a claim without disclosing the data that substantiates it. As organizations confront increasing demands to safeguard confidential information, meet rigorous regulatory requirements, and still operate collaboratively across different entities, this approach is becoming valuable well beyond digital asset ecosystems.A practical view of zero-knowledge proofsAt an enterprise scale, ZKPs support credible trust while revealing almost nothing. Rather than sharing raw information, organizations can offer proofs…